ADMA Biologics Inc (NASDAQ:ADMA)

3.81
Delayed Data
As of 11:26am ET
 -0.05 / -1.30%
Today’s Change
2.01
Today|||52-Week Range
5.44
+18.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash26.1M17.2M10.4M9.9M
 
 
 
 
 
Short Term Investment Cash13.6M-9.0M-6.8M-526.1K
 
 
 
 
 
Cash & Short Term Investments29.1M21.9M16.8M15.3M
 
 
 
 
 
 
ReceivablesReceivables0.00384.0K924.5K1.0M
 
 
 
 
 
InventoriesInventories1.7M1.7M3.4M5.0M
 
 
 
 
 
 
Current AssetsPrepaid Expenses298.7K143.6K111.0K313.9K
 
 
 
 
 
Current Assets31.1M24.1M21.3M21.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.8M4.1M4.2M4.2M
 
 
 
 
 
Depreciation-1.0M-1.3M-1.8M-2.2M
 
 
 
 
 
Other Assets162.2K298.8K27.2K27.2K
 
 
 
 
 
Total Assets32.0M27.2M23.7M23.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.7M1.8M2.1M2.6M
 
 
 
 
 
Short Term Debt12.7K13.8K15.1K6.1M
 
 
 
 
 
Accrued Expenses860.1K2.3M2.0M2.4M
 
 
 
 
 
Other Current Liabilities935.7K2.4M2.1M2.5M
 
 
 
 
 
Other Liabilities3.7M4.2M4.2M11.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt5.1M15.0M15.7M14.1M
 
 
 
 
 
Other Liabilities0.00476.8K128.7K98.1K
 
 
 
 
Total Liabilities10.4M21.2M22.9M28.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity21.6M6.0M821.0K-4.5M
 
 
 
 
 
Total Shareholder Equity21.6M6.0M821.0K-4.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding9.3M9.3M10.7M12.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.